NON CONTROLLING INTEREST (Details Narrative) |
1 Months Ended | |
|---|---|---|
Oct. 31, 2020 |
Jul. 28, 2016 |
|
| BioCorRx Pharmaceuticals, Inc [Member] | ||
| Ownership percentage held by company | 75.80% | |
| Ownership percentage held by former officers | 24.20% | |
| Joseph DeSanto MD [Member] | ||
| Descirption of management services agreement | a management fee equal to 65% of the Medical Corporation’s gross collected monthly revenue | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|